Bloomberg News and Videos — Page 279

Sheila Bair, former FDIC Chair and Senior Fellow at the Center for Financial Stability, shared her assessment of Federal Reserve Chair Kevin Warsh's first meeting and press conference. Bair commended Warsh for his measured and judicious communication, particularly his firm commitment to price stability and cautious approach to economic projections. She speaks with Romaine Bostick & Katie Greifeld on "The Close."

Alan Blinder, former Federal Reserve Vice Chair and current professor at Princeton University, provided insights on the Federal Reserve's newly outlined five task forces, emphasizing the market's keen interest in the Fed's communications strategy and its approach to using existing economic data. Blinder clarified that while the Fed produces some data such as industrial production and interest rates, most critical economic indicators like inflation, unemployment, and GDP come from other statistical agencies. He speaks with Romaine Bostick & Katie Greifeld on "The Close."

Jeffrey Rosenberg, portfolio manager of the systematic multi-strategy fund at BlackRock, reacts to the Federal Reserve's decision to keep rates unchanged and says there's a risk of overplaying the flattening yield curve. He speaks on "Bloomberg The Close."

Scott O'Neil, CEO of LIV Golf, joins Dani Burger and Scarlet Fu on "Bloomberg Deals." LIV Golf has begun laying the groundwork for a potential US bankruptcy filing if it fails to raise new funds, according to people familiar with the matter. The golf league is currently looking for money after its main backer, the Saudi Public Investment Fund, pulled its funding.

Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer, CEO Joaquin Duato said in an interview for an upcoming episode of The David Rubenstein Show: Peer to Peer Conversations. The comments set J&J apart from many of its rivals that are trying to develop or acquire obesity medicines following blockbuster weight-loss drugs from Eli Lilly & Co. and Novo Nordisk.

Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer, CEO Joaquin Duato said in an interview for an upcoming episode of The David Rubenstein Show: Peer to Peer Conversations. The comments set J&J apart from many of its rivals that are trying to develop or acquire obesity medicines following blockbuster weight-loss drugs from Eli Lilly & Co. and Novo Nordisk.

Federal Reserve Chair Kevin Warsh says his colleagues have been "very open" about changes during a news conference after the Fed decided to leave rate unchanged.

Chris Gordon, co-head of the global private equity at Bain Capital, joins Dani Burger on "Bloomberg Deals."

Scott O'Neil, CEO of LIV Golf, joins Dani Burger and Scarlet Fu on "Bloomberg Deals." LIV Golf has begun laying the groundwork for a potential US bankruptcy filing if it fails to raise new funds, according to people familiar with the matter. The golf league is currently looking for money after its main backer, the Saudi Public Investment Fund, pulled its funding.

Federal Reserve Chair Kevin Warsh vows the committee will deliver price stability. In his first press conference leading the Fed, Warsh said there was "rigorous debate" before members voted to keep rates unchanged.